社債
以下は、AbbVie Inc.の社債をワースト利回り順に並べたリストです。投資家は、市場の変動が激しい時期において、比較的安定した投資先として社債を選ぶ傾向にあります。価格、利回り、その他の指標を分析して、信頼できる投資先を見つけましょう。
シンボル | YTW % | 価格 % | クーポン % | 満期日 | 発行残高 | 額面金額 | S&P格付け | フィッチ格付け | 発行体 |
|---|---|---|---|---|---|---|---|---|---|
 ACT4176286Allergan Funding SCS 4.85% 15-JUN-2044 | 7.19% | 76.61% | 4.850% | 2044-06-15 | 65.23 M USD | 1,000.00 USD | NR | — | Allergan Funding SCS |
| ACT4218882Allergan Funding SCS 4.55% 15-MAR-2035 | 6.42% | 87.78% | 4.550% | 2035-03-15 | 107.65 M USD | 1,000.00 USD | NR | — | Allergan Funding SCS |
 ABBV6474595AbbVie Inc. 6.1% 15-SEP-2066 | 6.26% | 98.88% | 6.100% | 2066-09-15 | — | 1,000.00 USD | A− | — | AbbVie, Inc. |
| ABBV6474596AbbVie Inc. 6.0% 15-SEP-2056 | 6.17% | 98.80% | 6.000% | 2056-09-15 | — | 1,000.00 USD | A− | — | AbbVie, Inc. |
| ABBV5759196AbbVie Inc. 5.5% 15-MAR-2064 | 6.15% | 90.27% | 5.500% | 2064-03-15 | 1.5 B USD | 1,000.00 USD | A− | — | AbbVie, Inc. |
| ABBV6323042AbbVie Inc. 5.65% 15-MAR-2066 | 6.14% | 92.64% | 5.650% | 2066-03-15 | 500 M USD | 1,000.00 USD | A− | — | AbbVie, Inc. |
| ABBV5068387AbbVie Inc. 4.25% 21-NOV-2049 | 6.07% | 77.43% | 4.250% | 2049-11-21 | 5.75 B USD | 1,000.00 USD | A− | — | AbbVie, Inc. |
| ABBV5759195AbbVie Inc. 5.4% 15-MAR-2054 | 6.06% | 91.13% | 5.400% | 2054-03-15 | 3 B USD | 1,000.00 USD | A− | — | AbbVie, Inc. |
| ABBV4693583AbbVie Inc. 4.875% 14-NOV-2048 | 6.05% | 85.63% | 4.875% | 2048-11-14 | 1.75 B USD | 1,000.00 USD | A− | — | AbbVie, Inc. |
| US287YAW9AbbVie Inc. 4.45% 14-MAY-2046 | 6.05% | 81.71% | 4.450% | 2046-05-14 | 2 B USD | 1,000.00 USD | A− | — | AbbVie, Inc. |
| 4ABBAbbVie Inc. 4.7% 14-MAY-2045 | 6.01% | 85.33% | 4.700% | 2045-05-14 | 2.7 B USD | 1,000.00 USD | A− | — | AbbVie, Inc. |
| ABBV6009613AbbVie Inc. 5.6% 15-MAR-2055 | 6.01% | 94.35% | 5.600% | 2055-03-15 | 750 M USD | 1,000.00 USD | A− | — | AbbVie, Inc. |
| ABBV6323041AbbVie Inc. 5.55% 15-MAR-2056 | 6.00% | 93.70% | 5.550% | 2056-03-15 | 1.25 B USD | 1,000.00 USD | A− | — | AbbVie, Inc. |
| ABBV5068390AbbVie Inc. 4.75% 15-MAR-2045 | 5.97% | 86.59% | 4.750% | 2045-03-15 | 827.09 M USD | 1,000.00 USD | A− | — | AbbVie, Inc. |
| ABBV5759204AbbVie Inc. 5.35% 15-MAR-2044 | 5.93% | 93.67% | 5.350% | 2044-03-15 | 750 M USD | 1,000.00 USD | A− | — | AbbVie, Inc. |
| ABBV5068389AbbVie Inc. 4.85% 15-JUN-2044 | 5.92% | 88.05% | 4.850% | 2044-06-15 | 1.01 B USD | 1,000.00 USD | A− | — | AbbVie, Inc. |
| US00287YAM12AbbVie Inc. 4.4% 06-NOV-2042 | 5.88% | 84.59% | 4.400% | 2042-11-06 | 2.6 B USD | 1,000.00 USD | A− | — | AbbVie, Inc. |
| ABBV5068388AbbVie Inc. 4.625% 01-OCT-2042 | 5.87% | 87.19% | 4.625% | 2042-10-01 | 389.22 M USD | 1,000.00 USD | A− | — | AbbVie, Inc. |
| ABBV5068386AbbVie Inc. 4.05% 21-NOV-2039 | 5.62% | 85.43% | 4.050% | 2039-11-21 | 4 B USD | 1,000.00 USD | A− | — | AbbVie, Inc. |
| ABBV6474383AbbVie Inc. 5.45% 15-SEP-2038 | 5.60% | 99.30% | 5.450% | 2038-09-15 | — | 1,000.00 USD | A− | — | AbbVie, Inc. |
| ABBV6474384AbbVie Inc. 5.3% 15-SEP-2036 | 5.43% | 99.38% | 5.300% | 2036-09-15 | — | 1,000.00 USD | A− | — | AbbVie, Inc. |
| US287YAV1AbbVie Inc. 4.3% 14-MAY-2036 | 5.34% | 92.15% | 4.300% | 2036-05-14 | 1 B USD | 1,000.00 USD | A− | — | AbbVie, Inc. |
| ABBV6323043AbbVie Inc. 4.75% 15-MAR-2036 | 5.33% | 95.64% | 4.750% | 2036-03-15 | 1.5 B USD | 1,000.00 USD | A− | — | AbbVie, Inc. |
| US287YAR0AbbVie Inc. 4.5% 14-MAY-2035 | 5.30% | 94.43% | 4.500% | 2035-05-14 | 2.5 B USD | 1,000.00 USD | A− | — | AbbVie, Inc. |
| ABBV5082874AbbVie Inc. 4.55% 15-MAR-2035 | 5.30% | 94.96% | 4.550% | 2035-03-15 | 1.68 B USD | 1,000.00 USD | A− | — | AbbVie, Inc. |
| ABBV6009165AbbVie Inc. 5.2% 15-MAR-2035 | 5.25% | 99.52% | 5.200% | 2035-03-15 | 1 B USD | 1,000.00 USD | A− | — | AbbVie, Inc. |
| ABBV6474594AbbVie Inc. 5.05% 15-SEP-2033 | 5.17% | 99.59% | 5.050% | 2033-09-15 | — | 1,000.00 USD | A− | — | AbbVie, Inc. |
| ABBV5759203AbbVie Inc. 5.05% 15-MAR-2034 | 5.16% | 99.31% | 5.050% | 2034-03-15 | 3 B USD | 1,000.00 USD | A− | — | AbbVie, Inc. |
| ABBV6322510AbbVie Inc. 4.4% 15-MAR-2033 | 5.05% | 96.37% | 4.400% | 2033-03-15 | 1.25 B USD | 1,000.00 USD | A− | — | AbbVie, Inc. |
| ABBV6474593AbbVie Inc. 4.875% 15-SEP-2031 | 4.93% | 99.93% | 4.875% | 2031-09-15 | — | 1,000.00 USD | A− | — | AbbVie, Inc. |
| ABBV6322511AbbVie Inc. 4.125% 15-MAR-2031 | 4.84% | 97.00% | 4.125% | 2031-03-15 | 1.25 B USD | 1,000.00 USD | A− | — | AbbVie, Inc. |
| ABBV5759202AbbVie Inc. 4.95% 15-MAR-2031 | 4.81% | 100.54% | 4.950% | 2031-03-15 | 2 B USD | 1,000.00 USD | A− | — | AbbVie, Inc. |
| XS162262122Allergan Funding SCS 2.125% 01-JUN-2029 | 4.80% | 93.14% | 2.125% | 2029-06-01 | 36.46 M EUR | 1,000.00 EUR | NR | — | Allergan Funding SCS |
| ABBV6474592AbbVie Inc. 4.65% 15-MAR-2030 | 4.75% | 99.76% | 4.650% | 2030-03-15 | — | 1,000.00 USD | A− | — | AbbVie, Inc. |
| ABBV6009612AbbVie Inc. 4.875% 15-MAR-2030 | 4.73% | 100.47% | 4.875% | 2030-03-15 | 1 B USD | 1,000.00 USD | A− | — | AbbVie, Inc. |
| ABBV5084327AbbVie Inc. 3.2% 21-NOV-2029 | 4.65% | 95.62% | 3.200% | 2029-11-21 | 5.44 B USD | 1,000.00 USD | A− | — | AbbVie, Inc. |
| ABBV5758814AbbVie Inc. 4.8% 15-MAR-2029 | 4.59% | 100.49% | 4.800% | 2029-03-15 | 2.5 B USD | 1,000.00 USD | A− | — | AbbVie, Inc. |
| ABBV4693581AbbVie Inc. 4.25% 14-NOV-2028 | 4.49% | 99.48% | 4.250% | 2028-11-14 | 1.75 B USD | 1,000.00 USD | A− | — | AbbVie, Inc. |
| XS190919331Allergan Funding SCS 2.625% 15-NOV-2028 | 4.49% | 96.08% | 2.625% | 2028-11-15 | 72.11 M EUR | 1,000.00 EUR | NR | — | Allergan Funding SCS |
| ABBV6474583AbbVie Inc. 4.5% 18-AUG-2028 | 4.47% | 100.09% | 4.500% | 2028-08-18 | — | 1,000.00 USD | A− | — | AbbVie, Inc. |
| ABBV6009611AbbVie Inc. 4.65% 15-MAR-2028 | 4.45% | 100.29% | 4.650% | 2028-03-15 | 1.25 B USD | 1,000.00 USD | A− | — | AbbVie, Inc. |
| ABBV6322513AbbVie Inc. 3.775% 03-MAR-2028 | 4.41% | 99.06% | 3.775% | 2028-03-03 | 1.5 B USD | 1,000.00 USD | A− | — | AbbVie, Inc. |
| ABBV5758813AbbVie Inc. 4.8% 15-MAR-2027 | 4.35% | 100.24% | 4.800% | 2027-03-15 | 2.25 B USD | 1,000.00 USD | A− | — | AbbVie, Inc. |
| ABBV5084339AbbVie Inc. 2.95% 21-NOV-2026 | 4.10% | 99.69% | 2.950% | 2026-11-21 | 3.99 B USD | 1,000.00 USD | A− | — | AbbVie, Inc. |
| 4ABGAbbVie Inc. 1.25% 18-NOV-2031 | 3.35% | 90.03% | 1.250% | 2031-11-18 | 650 M EUR | 1,000.00 EUR | A− | — | AbbVie, Inc. |
| XS212591483AbbVie Inc. 2.625% 15-NOV-2028 | 3.25% | 98.65% | 2.625% | 2028-11-15 | 427.79 M EUR | 1,000.00 EUR | A− | — | AbbVie, Inc. |
| XS212591491AbbVie Inc. 2.125% 01-JUN-2029 | 3.20% | 97.16% | 2.125% | 2029-06-01 | 506.09 M EUR | 1,000.00 EUR | A− | — | AbbVie, Inc. |
| XS152090781AbbVie Inc. 2.125% 17-NOV-2028 | 3.07% | 97.96% | 2.125% | 2028-11-17 | 750 M EUR | 1,000.00 EUR | A− | — | AbbVie, Inc. |
| 4ABEAbbVie Inc. 0.75% 18-NOV-2027 | 2.96% | 97.30% | 0.750% | 2027-11-18 | 750 M EUR | 1,000.00 EUR | A− | — | AbbVie, Inc. |
| ABBV6322512AbbVie Inc. FRN 03-MAR-2028 | — | 100.12% | 4.117% | 2028-03-03 | 750 M USD | 1,000.00 USD | A− | — | AbbVie, Inc. |
| ABBV6474582AbbVie Inc. FRN 18-AUG-2028 | — | 100.06% | 0.000% | 2028-08-18 | — | 1,000.00 USD | — | — | AbbVie, Inc. |